Baader Bank Aktiengesellschaft Sells 3,171 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Baader Bank Aktiengesellschaft lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 59.1% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 2,190 shares of the company’s stock after selling 3,171 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in HCA Healthcare were worth $701,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. CreativeOne Wealth LLC purchased a new position in shares of HCA Healthcare in the first quarter valued at about $231,000. New Mexico Educational Retirement Board increased its holdings in shares of HCA Healthcare by 29.9% in the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares during the last quarter. Apexium Financial LP bought a new stake in shares of HCA Healthcare in the fourth quarter worth about $361,000. Sanders Capital LLC increased its holdings in shares of HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after purchasing an additional 456,738 shares during the last quarter. Finally, Todd Asset Management LLC increased its holdings in shares of HCA Healthcare by 17.2% in the fourth quarter. Todd Asset Management LLC now owns 226,563 shares of the company’s stock worth $61,326,000 after purchasing an additional 33,271 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HCA has been the topic of a number of analyst reports. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Deutsche Bank Aktiengesellschaft boosted their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. SVB Leerink boosted their price target on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Finally, Wells Fargo & Company boosted their price target on HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a report on Tuesday, July 30th. Four equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $349.28.

Insider Transactions at HCA Healthcare

In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Insiders sold 8,844 shares of company stock worth $3,185,932 in the last 90 days. Insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock traded up $0.31 during mid-day trading on Thursday, hitting $371.89. 724,637 shares of the stock were exchanged, compared to its average volume of 1,151,112. The firm has a fifty day moving average of $339.02 and a 200 day moving average of $327.76. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $375.64. The company has a market cap of $97.40 billion, a PE ratio of 18.49, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. HCA Healthcare’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period last year, the company posted $4.29 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 22.43 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.71%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.